Want to see HUN full AI Analyst Report?
Top Page
Huntsman
(NYSE:HUN)
Select Model
Select Model
Rating:49Neutral
Price Target:
$9.50
▼(-0.31% Downside)
Action:Reiterated
Date:08/26/26
The score is held down primarily by weak financial performance (TTM losses, compressed margins, and near-zero to negative free cash flow) and bearish technical trends (below major moving averages with negative MACD). These are partly offset by supportive valuation via a high dividend yield and a more constructive earnings-call outlook that highlights improving EBITDA/leverage and meaningful merger synergy potential, albeit with notable macro and execution risks.
Positive Factors
Olin merger advances strategic scale
Shareholder approval materially advances a combination designed to create a vertically integrated chemicals platform. Expanded feedstock access, product breadth and scale could improve competitiveness and resilience if regulatory and closing conditions are satisfied.
Negative Factors
Persistent losses and compressed margins
The return to losses after prior profitable years shows that revenue recovery has not yet translated into durable profitability. Weak margins leave Huntsman vulnerable to feedstock, energy and pricing pressure across cyclical end markets.
Read all positive and negative factors
Positive Factors
Negative Factors
Olin merger advances strategic scale
Shareholder approval materially advances a combination designed to create a vertically integrated chemicals platform. Expanded feedstock access, product breadth and scale could improve competitiveness and resilience if regulatory and closing conditions are satisfied.
Read all positive factors
Huntsman (HUN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.69B
Dividend Yield5.41%
Average Volume (3M)6.86M
Price to Earnings (P/E)―
Beta (1Y)1.02
Revenue Growth0.65%
EPS Growth45.36%
CountryUS
Employees6,000
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.99
Shares Outstanding175,378,620
10 Day Avg. Volume3,588,833
30 Day Avg. Volume6,861,742
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)0.63
Price to Sales (P/S)0.30
P/FCF Ratio14.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$11.50Price Target Upside20.67% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)-0.23
Revenue Forecast (FY)$6.13B
Huntsman Business Overview & Revenue Model
Company Description
Huntsman Corporation operates as a global producer and marketer of specialized organic chemical compounds. Its operations are structured across four distinct business divisions: Polyurethanes, Performance Products, Advanced Materials, and Textile ...
How the Company Makes Money
Huntsman makes money primarily by manufacturing and selling specialty chemical products and chemical intermediates to industrial and commercial customers worldwide. Revenue is generated through (1) Polyurethanes: sales of MDI and related downstrea...
Huntsman Earnings Call Summary
Earnings Call Date:Jul 30, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Positive
The call conveyed a cautiously optimistic operational picture: the company reported strong internal performance (notably a near doubling of EBITDA YoY), solid segment growth (Advanced Materials +8%, Polyurethanes ~4%, spray foam low double-digit), meaningful near- and multi-year upside from the planned Olin merger (~$300M identified synergies plus ~$100M+ additional benefits), and improving leverage (net debt ~$1.7B; leverage 6.1x → 5.4x with a path toward ~4x). Those positives are tempered by persistent macro and regional headwinds — soft North American housing, weak Chinese consumer confidence, volatile European energy costs (natural gas >50% higher recently), and the timing constraints of long-term supplier contracts — which could delay or dampen the realization of benefits. Overall, the operational and strategic positives outweigh the near-term macro and timing risks, but execution and demand recovery will be critical to fully deliver the upside.Positive Updates
Strong EBITDA Improvement Year-over-Year
Management stated they have "nearly doubled" EBITDA since Q2 of last year (approximately ~100% YoY improvement), demonstrating meaningful margin recovery vs. the prior-year period.
Negative Updates
Soft End-Market Demand (Housing & China)
North American housing stats softened and Chinese consumer confidence 'languishes,' management flagged weak demand as the primary constraint limiting upside despite cost recovery and price actions.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong EBITDA Improvement Year-over-Year
Management stated they have "nearly doubled" EBITDA since Q2 of last year (approximately ~100% YoY improvement), demonstrating meaningful margin recovery vs. the prior-year period.
Read all positive updates
Company Guidance
Management guided to a generally stable Q3 outlook with July order patterns described as flat-to-stable and Europe expected to be EBITDA‑positive in Q3; they reiterated a 2027 pro forma EBITDA target of roughly $500M, and balance‑sheet targets of net debt ≈$1.7B and net leverage improving from 6.1x (Q1) to 5.4x (Q2) toward ~4x by year‑end. On the Olin merger they forecast ~$300M of near‑term synergies (≈$75M purchasing/logistics, $75M epoxy/overlap, $150M SG&A, largely realizable within ~2 years) plus >$100M of chlorine/caustic replacement value (total ≈$400M+). Operational metrics called out include Q2 Advanced Materials growth +8%, Polyurethanes +4%, spray foam low‑double‑digit growth, elastomers up double digits, industry MDI utilization in the mid‑80s, a modest polyol benefit of ~$2–3M from outages, and European gas rising from ~$13–14 to >$20/MMBtu in recent weeks.Huntsman Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
58
Neutral
Cash Flow
41
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.90B | 5.68B | 6.04B | 6.11B | 8.02B | 7.67B |
| Gross Profit | 796.00M | 751.00M | 866.00M | 906.00M | 1.55B | 1.58B |
| EBITDA | 281.00M | 174.00M | 329.00M | 442.00M | 1.04B | 1.59B |
| Net Income | -171.00M | -275.00M | -189.00M | 101.00M | 460.00M | 1.04B |
Balance Sheet | ||||||
| Total Assets | 7.19B | 7.01B | 7.11B | 7.25B | 8.22B | 9.39B |
| Cash, Cash Equivalents and Short-Term Investments | 346.00M | 429.00M | 340.00M | 540.00M | 654.00M | 1.04B |
| Total Debt | 2.50B | 2.40B | 2.24B | 2.07B | 2.12B | 1.95B |
| Total Liabilities | 4.26B | 4.06B | 3.95B | 3.77B | 4.38B | 4.83B |
| Stockholders Equity | 2.69B | 2.75B | 2.96B | 3.25B | 3.62B | 4.38B |
Cash Flow | ||||||
| Free Cash Flow | -9.00M | 116.00M | 79.00M | -21.00M | 642.00M | 626.00M |
| Operating Cash Flow | 159.00M | 289.00M | 263.00M | 209.00M | 914.00M | 952.00M |
| Investing Cash Flow | -115.00M | -132.00M | -126.00M | 305.00M | -279.00M | -524.00M |
| Financing Cash Flow | -102.00M | -76.00M | -326.00M | -620.00M | -994.00M | -977.00M |
Huntsman Technical Analysis
Negative
9.53
Price Trends
11.01
Negative
12.59
Negative
11.85
Negative
Market Momentum
-0.48
Positive
36.16
Neutral
23.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HUN, the sentiment is Negative. The current price of 9.53 is below the 20-day moving average (MA) of 10.06, below the 50-day MA of 11.01, and below the 200-day MA of 11.85, indicating a bearish trend. The MACD of -0.48 indicates Positive momentum. The RSI at 36.16 is Neutral, neither overbought nor oversold. The STOCH value of 23.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HUN.
Huntsman Risk Analysis
Huntsman disclosed 30 risk factors in its most recent earnings report. Huntsman reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Huntsman Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | $21.91B | -16.90 | -6.58% | 4.69% | -1.20% | -30.03% | |
55 Neutral | $4.92B | -4.21 | -28.81% | 0.26% | -2.28% | 27.94% | |
49 Neutral | $1.69B | -9.52 | -6.28% | 4.00% | 0.65% | 45.36% | |
49 Neutral | $876.75M | -1.56 | -40.45% | 3.21% | 3.53% | -118.53% | |
47 Neutral | $442.01M | -24.98 | -2.20% | 3.04% | 2.96% | -122.83% | |
42 Neutral | $617.04M | -0.69 | 142.56% | ― | -1.40% | 2.39% |
* Basic Materials Sector Average
HUN
Huntsman
9.47
-1.21
-11.33%
CE
Celanese
45.00
-2.52
-5.30%
BAK
Braskem SA
1.68
-1.80
-51.72%
TROX
TRONOX
5.40
1.27
30.75%
ASIX
AdvanSix
16.49
-4.20
-20.32%
DOW
Dow Inc
30.51
6.77
28.50%
Huntsman Corporate Events
Business Operations and StrategyM&A TransactionsShareholder Meetings
Huntsman Shareholders Approve Merger Creating OlinHuntsman
Positive
Aug 25, 2026
On August 25, 2026, Huntsman held a special meeting where 76.23% of voting power was represented and stockholders overwhelmingly approved the merger agreement with Olin and the advisory vote on merger-related executive compensation. With roughly 9...
Legal ProceedingsM&A TransactionsRegulatory Filings and ComplianceShareholder Meetings
Huntsman Issues Supplemental Disclosures Amid Olin Merger Scrutiny
Negative
Aug 18, 2026
On June 15, 2026, Huntsman agreed to a merger-of-equals transaction with Olin, structured either as a direct merger or a two-step subsidiary merger, and the parties secured SEC effectiveness for a joint proxy statement/prospectus ahead of August 2...
Business Operations and StrategyExecutive/Board ChangesM&A Transactions
Huntsman Announces All-Stock Merger of Equals with Olin
Positive
Jun 16, 2026
On June 15, 2026, Huntsman Corporation entered into a definitive all‑stock merger of equals agreement with Olin Corporation to combine the two businesses under a new name, OlinHuntsman Corporation, in a transaction unanimously approved by bo...
Business Operations and StrategyM&A Transactions
Huntsman to Merge with Olin in All-Stock Deal
Positive
Jun 16, 2026
On June 16, 2026, Olin and Huntsman announced a definitive all‑stock merger of equals, signed June 15, 2026, to form OlinHuntsman Corporation, a $12.5 billion‑revenue integrated North American chemicals leader with expanded chlorine op...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.